| scholarly article | Q13442814 |
| P50 | author | Bert Vogelstein | Q827502 |
| Kenneth W. Kinzler | Q28031580 | ||
| Anthony P Shuber | Q116781906 | ||
| P2093 | author name string | Kerstin Schmidt | |
| Frank Diehl | |||
| Kent J Moore | |||
| Steve N Goodman | |||
| Kristine H Durkee | |||
| P2860 | cites work | Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations | Q24678861 |
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Accurate multiplex polony sequencing of an evolved bacterial genome | Q28265850 | ||
| Detection and quantification of mutations in the plasma of patients with colorectal tumors | Q34132363 | ||
| BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions | Q34540801 | ||
| Stool screening for colorectal cancer: molecular approaches | Q36000383 | ||
| Noninvasive testing for colorectal cancer: a review | Q36147339 | ||
| Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries | Q36486519 | ||
| Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test | Q42650892 | ||
| BEAMing up for detection and quantification of rare sequence variants. | Q51283236 | ||
| Improved fecal DNA test for colorectal cancer screening. | Q54567825 | ||
| DNA stabilization is critical for maximizing performance of fecal DNA-based colorectal cancer tests. | Q54648300 | ||
| Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. | Q54650748 | ||
| Serial Assessment of Human Tumor Burdens in Mice by the Analysis of Circulating DNA | Q57293420 | ||
| DNA integrity as a potential marker for stool-based detection of colorectal cancer. | Q65001903 | ||
| Improved marker combination for detection of de novo genetic variation and aberrant DNA in colorectal neoplasia | Q79326184 | ||
| An electrophoretic capture method for efficient recovery of rare sequences from heterogeneous DNA | Q80941340 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | feces | Q496 |
| colorectal cancer | Q188874 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 489-498 | |
| P577 | publication date | 2008-05-15 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients | |
| P478 | volume | 135 |
| Q48178985 | A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications |
| Q33590850 | An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. |
| Q54299767 | Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection. |
| Q33768253 | Application of nonsense-mediated primer exclusion (NOPE) for preparation of unique molecular barcoded libraries |
| Q40126434 | BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. |
| Q51752412 | Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer. |
| Q81939291 | Cell-free DNA resuscitated for tumor testing |
| Q38097524 | Challenges for the application of DNA methylation biomarkers in molecular diagnostic testing for cancer |
| Q36865058 | Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load. |
| Q38778558 | Circulating Plasma Tumor DNA. |
| Q93200678 | Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review |
| Q34354622 | Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer |
| Q92187283 | Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model |
| Q38800475 | Clinical Applications of Liquid Biopsies in Gastrointestinal Oncology |
| Q35127938 | Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. |
| Q28070230 | Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities |
| Q55924124 | Colorectal cancer |
| Q26768427 | Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances |
| Q33735234 | Colorectal cancer: from prevention to personalized medicine. |
| Q33868493 | Colorectal cancer: molecular features and clinical opportunities |
| Q92918626 | Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples |
| Q38374623 | Current and Emerging Applications of Droplet Digital PCR in Oncology |
| Q30472217 | Detection and quantification of rare mutations with massively parallel sequencing |
| Q47956458 | Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients |
| Q47095094 | Detection of KRAS G12D in colorectal cancer stool by droplet digital PCR. |
| Q33868284 | Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma |
| Q36142425 | Detection of fecal interferon-induced transmembrane protein messenger RNA for colorectal cancer screening |
| Q35951870 | Detection of hypermethylated vimentin in urine of patients with colorectal cancer |
| Q42936880 | Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing |
| Q36104229 | Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas |
| Q35946342 | Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord |
| Q26778581 | Developments in Screening Tests and Strategies for Colorectal Cancer |
| Q39980123 | Digital analysis of the expression levels of multiple colorectal cancer-related genes by multiplexed digital-PCR coupled with hydrogel bead-array |
| Q35447750 | Digital detection of multiple minority mutants and expression levels of multiple colorectal cancer-related genes using digital-PCR coupled with bead-array |
| Q40432468 | Droplet-Based Microfluidics Digital PCR for the Detection of KRAS Mutations. |
| Q48521971 | Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective. |
| Q35008971 | Emerging tactical strategies for fighting the war on cancer based on the genetic landscape |
| Q90664767 | Enrichment and Analysis of ctDNA |
| Q34322575 | Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. |
| Q53520406 | FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer. |
| Q26781466 | Fecal DNA testing for colorectal cancer screening: Molecular targets and perspectives |
| Q43337595 | Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms |
| Q26863327 | Free DNA--new potential analyte in clinical laboratory diagnostics? |
| Q100750413 | GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype |
| Q37536997 | Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening. |
| Q36717750 | Highly sensitive, non-invasive detection of colorectal cancer mutations using single molecule, third generation sequencing |
| Q48585692 | Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review |
| Q39157824 | Integrating liquid biopsies into the management of cancer |
| Q39872545 | K-RAS mutation in the screening, prognosis and treatment of cancer |
| Q34876437 | KRAS mutation analysis by PCR: a comparison of two methods |
| Q38636313 | Luminally expressed gastrointestinal biomarkers. |
| Q33642719 | MAGERI: Computational pipeline for molecular-barcoded targeted resequencing. |
| Q38194584 | Methylated DNA for monitoring tumor growth and regression: how do we get there? |
| Q34706624 | Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer |
| Q39031616 | Microsatellite instability typing in serum and tissue of patients with colorectal cancer: comparing real time PCR with hybridization probe and high-performance liquid chromatography. |
| Q26996463 | Molecular Technologies in the Clinical Diagnostic Laboratory |
| Q27010063 | Molecular markers for colorectal cancer screening |
| Q41134871 | Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer |
| Q28484970 | Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers |
| Q38285938 | Multi-target stool DNA test: a new high bar for noninvasive screening |
| Q26739049 | New trends in molecular and cellular biomarker discovery for colorectal cancer |
| Q33598163 | Next-generation stool DNA test accurately detects colorectal cancer and large adenomas |
| Q38700222 | Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies |
| Q38064739 | Noninvasive screening tests for colorectal cancer |
| Q28044590 | Overcoming mutation-based resistance to antiandrogens with rational drug design |
| Q37850818 | Predictive markers of colorectal cancer liver metastases |
| Q53198392 | Progress and potential of RAS mutation detection for diagnostics and companion diagnostics. |
| Q28238121 | Quantitative and sensitive detection of rare mutations using droplet-based microfluidics |
| Q59806883 | Radiomics and liquid biopsy in oncology: the holons of systems medicine |
| Q37805757 | Review of biomarkers in colorectal cancer |
| Q56158702 | Screening for Colorectal Cancer |
| Q33761814 | Sensitive digital quantification of DNA methylation in clinical samples |
| Q36295144 | Simple multiplexed PCR-based barcoding of DNA for ultrasensitive mutation detection by next-generation sequencing. |
| Q35984245 | Simple, multiplexed, PCR-based barcoding of DNA enables sensitive mutation detection in liquid biopsies using sequencing |
| Q36095650 | The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer. |
| Q60960098 | The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy |
| Q28251118 | The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia |
| Q58597311 | Towards the development of a cfDNA-based in-vitro diagnostic test for infectious diseases: A review of evidence for tuberculosis |
| Q55339974 | Transrenal DNA-based diagnosis of Strongyloides stercoralis (Grassi, 1879) infection: Bayesian latent class modeling of test accuracy. |
| Q40085419 | Tumor DNA: an emerging biomarker in head and neck cancer |
| Q104752904 | Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma |
| Q38238456 | Update on colon cancer screening: recent advances and observations in colorectal cancer screening |
| Q97424206 | ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper |
Search more.